Among healthcare ETFs, VHT stands out in my view as the most representative of the sector, in terms of performance, risk, and ...

The success of Eli Lilly & Co. 's weight-loss and diabetes drugs has pushed the company's stock to new heights, helping the ...

Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...

Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks ...

Looking at its longer-term performance, Eli Lilly's stock appreciated by 422.93% over the past five years, reflecting ...

Elanco Animal Health saw its share prices soar by 26.29 percent on Wednesday to end at $12.01 apiece following an impressive ...

Eli Lilly and Company has earned a “Moderate Buy” consensus from 21 research ... Between analyst optimism, big institutional backing, and strong fundamentals, Lilly’s stock story reads more like a ...

Eli Lilly’s (NYSE:LLY) stock faced a notable decline following the company’s announcement ... Analysts maintain a ‘Buy’ recommendation, with a target mean price of $991.9726, suggesting optimism about ...